Sino Biopharmaceutical Limited (SBHMY)
USD 8.34
(0.0%)
USD 8.34
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 26.19 Billion | 28.78 Billion | 26.86 Billion | 23.64 Billion | 24.23 Billion | 20.88 Billion |
| Cost of Revenue | 4.98 Billion | 5.79 Billion | 5.33 Billion | 5.18 Billion | 4.92 Billion | 4.19 Billion |
| Gross Profit | 21.2 Billion | 22.98 Billion | 21.52 Billion | 18.46 Billion | 19.3 Billion | 16.69 Billion |
| Operating Expenses | 15.53 Billion | 16.94 Billion | 17.18 Billion | 14.16 Billion | 14.21 Billion | 12.37 Billion |
| Selling, General and Administrative Expenses | 11.06 Billion | 12.56 Billion | 12.7 Billion | 11.62 Billion | 11.9 Billion | 10.26 Billion |
| Research and Development Expenses | 4.47 Billion | 4.33 Billion | 3.74 Billion | 2.62 Billion | 2.39 Billion | 2.09 Billion |
| Other Expenses | - | 153.98 Million | 326.32 Million | 67.19 Million | 48.93 Million | 35.84 Million |
| Cost and Expenses | 20.52 Billion | 22.74 Billion | 22.51 Billion | 19.34 Billion | 19.14 Billion | 16.56 Billion |
| Operating Income | 5.66 Billion | 6.69 Billion | 18.86 Billion | 4.88 Billion | 5.8 Billion | 4.97 Billion |
| Interest Expense | 495.23 Million | 439.05 Million | 308.61 Million | 323.36 Million | 229.95 Million | 153.26 Million |
| Income Tax Expense | 797.26 Million | 775.98 Million | 1.95 Billion | 672.37 Million | 889.44 Million | 696.23 Million |
| Earnings before Tax | 5.4 Billion | 5.77 Billion | 18.57 Billion | 5.01 Billion | 5.58 Billion | 11.42 Billion |
| Net Income | 1.84 Billion | 2.54 Billion | 14.6 Billion | 2.77 Billion | 2.76 Billion | 9.04 Billion |
| Earnings Per Share Basic | 0.08 | 2.73 | 15.57 | 2.95 | 2.94 | 9.75 |
| Earnings Per Share Diluted | 0.10 | 2.43 | 14.65 | 2.95 | 2.94 | 9.75 |
| Weighted Average Shares Outstanding | 23.39 Billion | 931.11 Million | 938.43 Million | 940.01 Million | 940.55 Million | 927.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.52 Billion | 950.86 Million | 964.14 Million | 940.01 Million | 940.55 Million | 927.42 Million |
| Gross Margin | 0.81 | 0.80 | 0.80 | 0.78 | 0.80 | 0.80 |
| EBIT Margin | 0.27 | 0.27 | 0.74 | 0.28 | 0.30 | 0.29 |
| Profit Margin | 0.07 | 0.09 | 0.54 | 0.12 | 0.11 | 0.43 |
| EBITDA | 6.97 Billion | 6.69 Billion | 19.87 Billion | 6.54 Billion | 7.36 Billion | 6.14 Billion |
| Earnings Before Tax Margin | 0.22 | 0.23 | 0.70 | 0.21 | 0.24 | 0.24 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 2.19 Billion | 26.19 Billion | 1.5 Billion | - | 2.2 Billion | 7.63 Billion |
| Cost of Revenue | 394.24 Million | 4.98 Billion | 239.48 Million | - | 469.84 Million | 1.62 Billion |
| Gross Profit | 1.8 Billion | 21.2 Billion | 1.26 Billion | - | 1.73 Billion | 6.01 Billion |
| Operating Expenses | 1.3 Billion | 15.91 Billion | 920.19 Million | - | 1.26 Billion | 4.4 Billion |
| Selling, General and Administrative Expenses | 947.36 Million | - | 637.55 Million | - | 926.96 Million | 3.22 Billion |
| Research and Development Expenses | 357.32 Million | - | 282.64 Million | - | 340.1 Million | 1.17 Billion |
| Other Expenses | - | 176.57 Million | - | - | - | - |
| Cost and Expenses | 1.69 Billion | 20.9 Billion | 1.15 Billion | - | 1.73 Billion | 6.02 Billion |
| Operating Income | 501.03 Million | 5.43 Billion | 349.38 Million | - | 467.22 Million | 1.56 Billion |
| Interest Expense | 21.3 Million | 495.23 Million | 26.4 Million | - | - | - |
| Income Tax Expense | 85.1 Million | 797.26 Million | 37.65 Million | - | 75.7 Million | 262.37 Million |
| Earnings before Tax | 513.75 Million | 5.4 Billion | 344.3 Million | - | 496.83 Million | 1.61 Billion |
| Net Income | 181.2 Million | 1.84 Billion | 148.27 Million | - | 181.61 Million | 629.39 Million |
| Earnings Per Share Basic | 0.20 | - | 0.16 | - | 0.20 | 0.68 |
| Earnings Per Share Diluted | 0.20 | - | 0.16 | - | 0.20 | 0.68 |
| Weighted Average Shares Outstanding | 920.41 Million | 926.45 Million | 917.35 Million | 926.45 Million | 926.45 Million | 926.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 920.49 Million | 926.45 Million | 917.35 Million | 926.45 Million | 926.45 Million | 926.45 Million |
| Gross Margin | 0.82 | 0.81 | 0.84 | - | 0.79 | 0.79 |
| EBIT Margin | 0.26 | - | 0.27 | - | 0.25 | 0.24 |
| Profit Margin | 0.08 | 0.07 | 0.10 | - | 0.08 | 0.08 |
| EBITDA | 570.08 Million | - | 401.29 Million | - | 558.66 Million | 1.86 Billion |
| Earnings Before Tax Margin | 0.23 | 0.21 | 0.23 | - | 0.21 | 0.20 |
FOX
CNFRZ
JDVB
1104
8111
CHSCL